These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9200451)

  • 21. Thymocyte/splenocyte-derived CD4+CD25+Treg stimulated by anti-CD200R2 derived dendritic cells suppress mixed leukocyte cultures and skin graft rejection.
    Gorczynski RM
    Transplantation; 2006 Apr; 81(7):1027-34. PubMed ID: 16612280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Requirement of CD4+ T cells and antigen-presenting cells for primary in vitro generation of CD8+ cytotoxic T cells against Ld-binding self-peptide p2Ca.
    Wada H; Ono T; Uenaka A; Monden M; Nakayama E
    Immunology; 1995 Apr; 84(4):633-7. PubMed ID: 7790038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C transgenic mouse.
    Margenthaler JA; Flye MW
    J Surg Res; 2005 Jun; 126(2):160-6. PubMed ID: 15919414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective immunity in BALB/c mice against the simian virus 40-induced mKSA tumor resulting from injection of recombinant large T antigen. Requirement of CD8+ T lymphocytes.
    Zerrahn J; Utermöhlen O; Warnecke G; Deppert W; Lehmann-Grube F
    J Immunol; 1996 May; 156(10):3919-24. PubMed ID: 8621931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new T-cell receptor transgenic model of the CD4+ direct pathway: level of priming determines acute versus chronic rejection.
    Brennan TV; Hoang V; Garrod KR; Liu FC; Hayden T; Kim J; Kang SM
    Transplantation; 2008 Jan; 85(2):247-55. PubMed ID: 18212630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of stable CD4+ and CD8+ T cell lines from patients immunized with ras oncogene-derived peptides reflecting codon 12 mutations.
    Abrams SI; Khleif SN; Bergmann-Leitner ES; Kantor JA; Chung Y; Hamilton JM; Schlom J
    Cell Immunol; 1997 Dec; 182(2):137-51. PubMed ID: 9514698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
    Frey AB
    J Immunol; 1996 May; 156(10):3841-9. PubMed ID: 8621922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
    Gorczynski RM
    Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of TL, H-2, and chimeric H-2/TL genes in transgenic mice: abnormal thymic differentiation and T-cell lymphomas in a TL transgenic strain.
    Hamasima N; Takahashi T; Taguchi O; Nishizuka Y; Stockert E; Old LJ; Obata Y
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):7995-9. PubMed ID: 2813374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.
    Kawai M; Obata Y; Hamasima N; Takahashi T; Uenaka A; Monden M; Mori T; Shiku H; Nakayama E
    J Exp Med; 1991 Jan; 173(1):261-4. PubMed ID: 1670639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rejection of human xenoskins by non-CD4 T-cell populations in mice.
    Uchida T; Tomita Y; Zheng QW; Kishihara K; Nomoto K; Yasui H
    Transplant Proc; 1996 Apr; 28(2):662. PubMed ID: 8623332
    [No Abstract]   [Full Text] [Related]  

  • 38. Rejection of transgenic skin expressing a xeno-class I antigen is CD4-dependent and CD8-independent.
    Auchincloss H; Moses R; Conti D; Sundt T; Smith C; Sachs DH; Winn HJ
    Transplant Proc; 1990 Jun; 22(3):1059-60. PubMed ID: 1971971
    [No Abstract]   [Full Text] [Related]  

  • 39. The critical role of mouse CD4+ cells in the rejection of highly disparate xenogeneic pig thymus grafts.
    Zhao Y; Swenson K; Wekerle T; Rodriguez-Barbosa JI; Arn JS; Sykes M
    Xenotransplantation; 2000 May; 7(2):129-37. PubMed ID: 10961297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.
    Suárez IM; Benvenutti LA; Noronh I; Van Kaer L; Kalil J; Coelho V
    Transpl Immunol; 2002 May; 9(2-4):101-10. PubMed ID: 12180815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.